Savara Incis A Clinical Stage Biopharmaceutical Company Based In Langhornepennsylvaniathe Company Specializes In Developing Therapies For Rare Respiratory Diseaseswith A Particular Focus On Autoimmune Pulmonary Alveolar Proteinosisapap This Rare Lung Disorder Involves Abnormal Surfactant Accumulationand Savara Aims To Address The Significant Unmet Medical Needs Of Patients Affected By This Condition The Lead Product Candidatemolbreevia Molgramostim Inhalation Solution Is Currently In Phase 3 Developmentit Is An Inhaled Recombinant Granulocyte Macrophage Colony Stimulating Factorgm Csfdesigned To Restore Gm Csf Signalingwhich Is Essential For Surfactant Clearance In Apap Patientssavara Collaborates With Pari Pharma Gmbh To Utilize The Eflowanebulizer System For Optimized Drug Deliverythe Company Is Committed To Advancing Its Therapies Through Regulatory Approval And Commercializationleveraging Its Expertise In Orphan Drug Development And Pulmonary Medicine
No conferences found for this company.
| Company Name | Savara Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
